首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Benzimidazole derivatives endowed with potent antileishmanial activity
【2h】

Benzimidazole derivatives endowed with potent antileishmanial activity

机译:苯并咪唑衍生物具有很强的抗菌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two sets of benzimidazole derivatives were synthesised and tested for activity against promastigotes of and . Most of the tested compounds resulted active against both species, with IC values in the low micromolar/sub-micromolar range. Among the set of 2-(long chain)alkyl benzimidazoles, whose heterocyclic head was quaternised, compound resulted about 100-/200-fold more potent than miltefosine, even if the selectivity index (SI) versus HMEC-1 cells was only moderately improved. In the set of 2-benzyl and 2-phenyl benzimidazoles, bearing a basic side chain in position 1, compound (2-(4-chlorobenzyl)-1-lupinyl-5-trifluoromethylbenzimidazole) was 12-/7-fold more potent than miltefosine, but exhibited a further improved SI. Therefore, compounds and represent interesting hit compounds, susceptible of structural modification to improve their safety profiles.
机译:合成了两组苯并咪唑衍生物,并测试了其对前体和后体的活性。大多数测试化合物对两种物质均具有活性,IC值在低微摩尔/亚微摩尔范围内。在杂环头被季铵化的2-(长链)烷基苯并咪唑组中,即使相对于HMEC-1细胞的选择性指数(SI)仅得到中等程度的改善,化合物的效果也比米替福辛高约100- / 200倍。在位置1处带有碱性侧链的2-苄基和2-苯基苯并咪唑类化合物中,化合物(2-(4-氯苄基)-1-卢平基-5-三氟甲基苯并咪唑)的效力比其高12- / 7倍miltefosine,但SI进一步改善。因此,这些化合物代表令人关注的命中化合物,易于进行结构修饰以改善其安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号